AGPS and glioblastoma: Derivatives S1, S3, S8, and S10 significantly inhibited the growth of U87MG and U251 glioblastoma cells by targeting AGPS. These derivatives improved TMZ’s absorption, distribution, metabolism, and excretion (ADME) properties, reduced toxicity, and enhanced antitumor efficacy